查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1580065

胱胺酸尿市場：按類型、產品、給藥途徑、最終用戶分類 - 全球預測 2025-2030

Cystinuria Market by Type (Type I, Type II, Type III), Offering (Medications, Therapy), Route of Administration, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胱胺酸尿市值為1.0156億美元，預計到2024年將達到1.0629億美元，複合年成長率為4.82%，到2030年將達到1.413億美元。

胱胺酸尿症是一種遺傳性疾病，其特徵是在腎臟中形成胱胺酸結石，在更廣泛的腎臟病學和泌尿系統治療領域提出了目標市場。解決胱胺酸尿症的必要性源自於其慢性性質和腎結石復發的可能性，如果治療不當，可能會導致腎臟損傷。範圍主要包括硫醇藥物、水合療法和旨在減少胱胺酸結石形成的飲食管理產品等醫藥產品。最終用途範圍從醫院和診所到專業藥房，受患者特定治療和持續管理需求的驅動。

主要市場統計
基準年[2023] 10156萬美元
預測年份 [2024] 1.0629億美元
預測年份 [2030] 1.413 億美元
複合年成長率（%） 4.82%

市場成長受到遺傳疾病盛行率上升、基因檢測進步以及腎臟健康醫療保健意識增強的影響。然而，與其他腎臟疾病相比，它面臨著對胱胺酸尿症的認知較低、基因治療成本高昂以及報銷政策不足等挑戰，尤其是在新興市場。治療機會在於加強以患者為中心的治療模式、開發非侵入性診斷以及利用遠端醫療進行患者管理以推動市場向前發展。公司可以透過投資新療法的研發來利用這些趨勢，特別是那些具有更高功效和安全性的療法。此外，透過促進與醫療保健提供者和醫療機構的合作，我們可以透過教育措施和全面護理計劃來提高市場滲透率。

遺傳分析和個人化醫療的創新有望推動胱胺酸尿症治療的進步。將人工智慧整合到疾病管理的預測模型中是一個令人興奮的研究途徑。儘管該市場是利基市場，但其本質要求高度專業化和技術進步，儘管存在進入壁壘，但現有參與者和創新的新進入者仍有顯著成長的潛力。企業可以透過瞄準新興市場的擴張機會、提高供應鏈效率以及透過全面的市場教育提高滲透率來實現成長。策略建議包括專注於降低成本策略，以應對報銷挑戰並增強可及性和市場擴張。

市場動態：揭示快速發展的胱胺酸尿市場的關鍵市場洞察

供需的動態交互作用正在改變胱胺酸尿市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 被診斷出患有胱胺酸尿症的人數增加
    • 對基因研究和診斷技術的大量投資
  • 市場限制因素
    • 與藥物治療和頻繁就診相關的高成本胱胺酸尿症
  • 市場機會
    • 開發能夠快速準確檢測胱胺酸尿症的診斷工具
    • 政府透過優惠政策支持罕見疾病研究
  • 市場挑戰
    • 對用於治療胱胺酸尿症的先進治療方法認知不足

波特的五力：駕馭胱胺酸尿市場的策略工具

波特的五力框架是了解胱胺酸尿市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胱胺酸尿市場的外部影響

外部宏觀環境因素在塑造胱胺酸尿市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解胱胺酸尿市場的競爭狀況

對胱氨酸尿市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣胱胺酸尿市場供應商績效評估

FPNV定位矩陣是評估胱胺酸尿市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製胱胺酸尿市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，胱胺酸尿市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 越來越多的人被診斷出患有胱胺酸尿症
      • 對基因研究和診斷技術的大量投資
    • 抑制因素
      • 與藥物治療和頻繁就醫相關的高額費用
    • 機會
      • 開發診斷工具以更快、更準確地檢測胱胺酸尿症
      • 政府透過優惠政策支持罕見疾病研究
    • 任務
      • 對治療胱胺酸尿症的先進治療方法認知有限
  • 市場區隔分析
    • 類型：研發下一代胱胺酸尿症的崛起
    • 最終用途：專科診所對胱胺酸尿症治療的需求正在增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章胱氨酸尿市場：依類型

  • Ⅰ型
  • II型
  • Ⅲ型

第 7 章 胱胺酸尿市場：透過提供

  • 藥品
    • Captopril
    • Penicillamine
    • 硫普羅寧
  • 治療
    • 銅注射療法
    • 基因治療

第8章胱胺酸尿市場：依給藥途徑

  • 可注射的
  • 口服

第 9 章 胱胺酸尿市場：依最終使用者分類

  • 居家護理
  • 醫院
  • 專科診所

第10章美洲胱氨酸尿市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太胱胺酸尿市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲胱胺酸尿市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 治療胱胺酸尿症的新型緩釋片劑在美國推出，並附帶病患援助計劃
    • FDA 核准 ADV7103 為治療罕見腎臟病胱胺酸尿症的孤兒藥
    • 新資金促進了罕見腎結石疾病胱胺酸尿症的研究
  • 戰略分析和建議

公司名單

  • Advicenne SA
  • Amerigen Pharmaceuticals Limited
  • Amneal Pharmaceuticals LLC
  • Aurobindo Pharma
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cycle Pharmaceuticals Limited
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Merck & Co., Inc.
  • Orsini Specialty Pharmacy
  • Revive Therapeutics Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Travere Therapeutics, Inc.
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
Product Code: MRR-6A132FD32B22

The Cystinuria Market was valued at USD 101.56 million in 2023, expected to reach USD 106.29 million in 2024, and is projected to grow at a CAGR of 4.82%, to USD 141.30 million by 2030.

Cystinuria, a genetic disorder characterized by the formation of cystine stones in the kidneys, presents a targeted market within the broader nephrology and urological treatment sectors. The necessity for addressing cystinuria arises from its chronic nature and potential to cause recurrent nephrolithiasis, leading to renal damage if not properly managed. The application scope primarily encompasses pharmaceuticals like thiol drugs, hydration therapies, and dietary management products aimed at reducing cystine stone formation. End-use scenarios extend from hospitals and clinics to specialty pharmacies, given the need for tailored treatments and ongoing patient management.

KEY MARKET STATISTICS
Base Year [2023] USD 101.56 million
Estimated Year [2024] USD 106.29 million
Forecast Year [2030] USD 141.30 million
CAGR (%) 4.82%

Market growth is influenced by a rising prevalence of genetic disorders, advancements in genetic testing, and increased healthcare awareness regarding kidney health. However, the market faces challenges such as limited awareness about cystinuria compared to other kidney diseases, high costs associated with genetic therapies, and insufficient reimbursement policies, particularly in developing regions. Opportunities lie in enhancing patient-centric treatment models, developing non-invasive diagnostic methods, and leveraging telehealth for patient management, propelling the market forward. Companies can capitalize on these trends by investing in R&D for novel therapeutic agents, especially those with improved efficacy and safety profiles. Furthermore, fostering collaborations with healthcare providers and institutions can augment market penetration through educational initiatives and integrated care programs.

Innovations in genetic analysis and personalized medicine hold promise in advancing cystinuria treatment. The integration of artificial intelligence in predictive modeling for disease management is an exciting avenue for research. While the market is niche, its nature demands high specialization and technological advancement, creating a barrier to entry but offering substantial growth for established players or innovative newcomers. Business growth can thrive by targeting scaling opportunities in emerging markets, refining supply chain efficiencies, and ensuring comprehensive market education to improve adoption rates. Strategic recommendations include focusing on cost reduction strategies and addressing reimbursement challenges to enhance accessibility and market expansion.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cystinuria Market

The Cystinuria Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of individuals diagnosed with cystinuria
    • Significant investments in genetic research and diagnostic technologies
  • Market Restraints
    • High costs associated with medication and frequent medical consultations cystinuria
  • Market Opportunities
    • Development of diagnostic tools to enable quicker and accurate detection of cystinuria
    • Governmental support for rare disease research through favorable policies
  • Market Challenges
    • Limited awareness toward advanced therapies used to treat cystinuria

Porter's Five Forces: A Strategic Tool for Navigating the Cystinuria Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cystinuria Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cystinuria Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cystinuria Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cystinuria Market

A detailed market share analysis in the Cystinuria Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cystinuria Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cystinuria Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cystinuria Market

A strategic analysis of the Cystinuria Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cystinuria Market, highlighting leading vendors and their innovative profiles. These include Advicenne SA, Amerigen Pharmaceuticals Limited, Amneal Pharmaceuticals LLC, Aurobindo Pharma, Bausch Health Companies Inc., Bayer AG, Cycle Pharmaceuticals Limited, Dr. Reddy's Laboratories, Lupin Limited, Merck & Co., Inc., Orsini Specialty Pharmacy, Revive Therapeutics Ltd., Teva Pharmaceutical Industries Ltd., Travere Therapeutics, Inc., and Zhejiang Huahai Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cystinuria Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Type I, Type II, and Type III.
  • Based on Offering, market is studied across Medications and Therapy. The Medications is further studied across Captopril, Penicillamine, and Tiopronin. The Therapy is further studied across Copper Injection Therapy and Gene Therapy.
  • Based on Route of Administration, market is studied across Injectable and Oral.
  • Based on End-User, market is studied across Home Care, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of individuals diagnosed with cystinuria
      • 5.1.1.2. Significant investments in genetic research and diagnostic technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with medication and frequent medical consultations cystinuria
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of diagnostic tools to enable quicker and accurate detection of cystinuria
      • 5.1.3.2. Governmental support for rare disease research through favorable policies
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness toward advanced therapies used to treat cystinuria
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Rising R&D to develop the next generation of cystinuria
    • 5.2.2. End-use: Rising need for cystinuria therapy across specialty clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cystinuria Market, by Type

  • 6.1. Introduction
  • 6.2. Type I
  • 6.3. Type II
  • 6.4. Type III

7. Cystinuria Market, by Offering

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Captopril
    • 7.2.2. Penicillamine
    • 7.2.3. Tiopronin
  • 7.3. Therapy
    • 7.3.1. Copper Injection Therapy
    • 7.3.2. Gene Therapy

8. Cystinuria Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral

9. Cystinuria Market, by End-User

  • 9.1. Introduction
  • 9.2. Home Care
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Americas Cystinuria Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cystinuria Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cystinuria Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. New Delayed-Release Tablets for Cystinuria Launched in US with Support Program for Patients
    • 13.3.2. FDA Recognizes ADV7103 as Orphan Drug for Rare Kidney Disorder Cystinuria
    • 13.3.3. New Funding Boosts Research into Rare Kidney Stone Disease Cystinuria
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advicenne SA
  • 2. Amerigen Pharmaceuticals Limited
  • 3. Amneal Pharmaceuticals LLC
  • 4. Aurobindo Pharma
  • 5. Bausch Health Companies Inc.
  • 6. Bayer AG
  • 7. Cycle Pharmaceuticals Limited
  • 8. Dr. Reddy's Laboratories
  • 9. Lupin Limited
  • 10. Merck & Co., Inc.
  • 11. Orsini Specialty Pharmacy
  • 12. Revive Therapeutics Ltd.
  • 13. Teva Pharmaceutical Industries Ltd.
  • 14. Travere Therapeutics, Inc.
  • 15. Zhejiang Huahai Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. CYSTINURIA MARKET RESEARCH PROCESS
  • FIGURE 2. CYSTINURIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CYSTINURIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CYSTINURIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYSTINURIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYSTINURIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CYSTINURIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CYSTINURIA MARKET DYNAMICS
  • TABLE 7. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CYSTINURIA MARKET SIZE, BY TYPE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CYSTINURIA MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYSTINURIA MARKET SIZE, BY CAPTOPRIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CYSTINURIA MARKET SIZE, BY PENICILLAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYSTINURIA MARKET SIZE, BY TIOPRONIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYSTINURIA MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CYSTINURIA MARKET SIZE, BY COPPER INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYSTINURIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CYSTINURIA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYSTINURIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CYSTINURIA MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CYSTINURIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CYSTINURIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CYSTINURIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYSTINURIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CYSTINURIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. CYSTINURIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. CYSTINURIA MARKET, FPNV POSITIONING MATRIX, 2023